Browse > Home / FDA News / FDA Notifies Clinical Researcher of Disqualification Proceeding

FDA Notifies Clinical Researcher of Disqualification Proceeding

September 10, 2009

FDA Notifies Clinical Researcher of Disqualification Proceeding
The FDA has told David Loucks, a drug clinical trial student from Centennial, Colo., that he faces possible disqualification for failing to properly supervise a study and allowing others to forge his signature on study documents, according to an Aug. 18 see posted recently on the FDA’sitting website. Loucks admitted in a May 7, 2008 affidavit that a account of cogitation documents were signed or initialed with his credit by other mob, the notice says.

Written by Samanta · Filed Under FDA News